St. Louis, Kansas City, Springfield, Columbia Indian Community - StLouisIndian.net
| | | | | | | | | | | |
 


 

CMFRI comes up with natural remedy for fatty liver disease from seaweeds

Kerala,National,Health/Medicine

Author : Indo Asian News Service

Health/Medicine, National, Kerala, India Read Latest News and Articles

Share With Your Friends



Add an Article

View All Contributions

Add To My Favorite

Add A Picture

Kochi, Sep 27 (IANS) The Central Marine Fisheries Research Institute (CMFRI), here has come up with a nutraceutical product from select seaweeds to treat non-alcoholic fatty liver disease (NAFLD).

Named as CadalminTM LivCure extract, the product is a unique blend of 100 per cent natural bioactive ingredients extracted from seaweeds with an eco-friendly green technology to improve liver health.

This is the ninth such product from marine organisms being developed by the CMFRI which already has brought out nutraceuticals to combat a series of lifestyle diseases, such as type-2 diabetes, arthritis, cholesterol, hypertension, hypothyroidism and osteoporosis, and to improve immunity.

Out of these nutraceuticals, eight products are from seaweeds and one from green mussel.

Kajal Chakraborty, Principal Scientist at the Marine Biotechnology, Fish Nutrition and Health Division of the CMFRI led the research works to develop the product.

Chakraborty said that the bioactive pharmacophore leads from seaweeds were used to develop the nutraceutical product.

"Pre-clinical trials showed that LivCure extract proved to have the potential to inhibit different enzymes and various target receptors associated with dyslipidemia and pathophysiology leading to NAFLD. This helps improve liver health, reduce the disposition of fatty substances, and maintain other liver/lipid parameters within the clinically acceptable limits", said Chakraborty.

He points out that the nutraceutical does not have any side effects as established by detailed preclinical trials.

"It has proved that long-term oral administration of this product will not lead to general organ or systemic toxicity. The technology will be out-licensed soon to those in the pharmaceutical industry for commercial production of the nutraceutical," added Chakraborty.

A.A Gopalakrishnan, director of CMFRI said for the last few years, the CMFRI has been intensively focusing on research on seaweeds mainly for developing natural products beneficial to improving human health.

"Seaweeds are often termed as the wonder herbs of the ocean due to their potential pharmaceutical properties. Recently, this marine macro flora is gaining immense attention in nutraceutical industries due to its protective function against various chronic diseases", said Gopalakrishnan and added that intensive and continuous research on extracting bioactive compounds from the seaweeds has helped CMFRI win much national recognition.

--IANS

sg/shb/


Copyright and Disclaimer: All news and images appearing in our news section, search engines and social media are provided by IANS. If you face any issues related to the content/images, please contact our news service provider directly. We are not liable/responsible for any content/images related to the news service provider.


Latest News

View More News


More News Articles

After 'The Broken News 2', Akshay Oberoi says agendas still dictate news

IPL 2024: Reading the batters, not trying much - the Kuldeep Yadav formula of holding your own

Karan Vohra talks about how he bonded with child actor Nihan Jain

Neha Kakkar grooves with 'Gulabi Sadi' hitmaker Sanju Rathod on 'Superstar Singer 3'

Neha Kakkar, grooves with 'Gulabi Sadi' hitmaker Sanju Rathod on 'Superstar Singer 3'